Nepal received 600,000 doses of Covishield, the India-made AstraZeneca type vaccine, through the COVAX facility on Wednesday.
It is the third consignment and part of 6,039,000 doses of the AstraZeneca vaccine committed by COVAX. “We have received 600,000 doses of the Covishield vaccine through the COVAX facility,” said Badebabu Thapa, a senior officer at the Logistic Management Section under the Department of Health Services.
Earlier, on December 1, Nepal received 972,000 doses and on November 29 725,550 doses of Covishield through COVAX.
Similarly, the country will receive 1,400,000 doses of Moderna vaccines today.
Nepal so far has received 25,649,840 of Covid-19 vaccines—Vero Cell, AstraZeneca, Janssen, Pfizer-BioNTech and Moderna.
As of Wednesday, 8,869,067 people (29.2 percent of the total population) have been fully vaccinated in Nepal.
